Tanglao, B-jay .
HRN: 21-88-51 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/26/2023
02/02/2023
IV
575mg
Q8
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes